|Name: Glenn Bauman
Position: Professor and Chair/Chief Department of Oncology
Affiliation: Associate Scientist, Lawson Research Institute
Areas of Expertise: radiotherapy, brain tumors, genitourinary tumors
|Brief Description of Research:|
|I am a Radiation Oncologist specializing in Genitourinary and Central Nervous System Malignancies. I am also a Professor and Chair/Chief in the Department of Oncology, a cross-appointed Professor in the Department of Medical Biophysics and an Associate Scientist in the Lawson Health Research Institute. I received both my medical degree from the University of Western Ontario, where I also completed my residency in Radiation Oncology. I subsequently completed fellowship in Radiation Oncology in the area of adult and pediatric brain tumor treatment was completed at the University of California at San Francisco. My primary areas of clinical practice are in genitourinary and central nervous system tumors and areas of research interest are clinical trials and multi-modality image guided radiotherapy and cancer imaging. I collaborate closely with imaging scientists at Western, Robarts and Lawson and clinical collaborators in medical imaging, pathology, urology and neurosciences. For treating primary and metastatic brain tumors we continue to develop our precision radiotherapy techniques combined with non-invasive frame system and utilizing image guidance to deliver stereotactic radiotherapy for the treatment of recurrent primary and metastatic brain tumors. I am also interested in novel functional imaging techniques for the characterization of primary and metastatic brain tumors.|
|5 Select Publications (trainees underlined):|
|Belliveau JG, Jensen MD, Stewart JMP, Solovey I, Klassen LM, Bauman GS, Menon RS. Prediction of radiation necrosis in a rodent model using magnetic resonanceimaging apparent transverse relaxation ([Formula: see text]). Phys Med Biol. 2018 Jan 26;63(3):035010.
Belliveau JG, Bauman GS, Tay KY, Ho D, Menon RS. Initial Investigation into Microbleeds and White Matter Signal Changes following Radiotherapy for Low-Grade and Benign Brain Tumors Using Ultra-High-Field MRI Techniques. AJNR Am J Neuroradiol. 2017 Dec;38(12):2251-2256.
Yartsev S, Bauman G. Optimization of brain metastases radiotherapy with TomoHDA. Med Dosim. 2017 Spring;42(1):53-56.
Belliveau JG, Bauman G, Macdonald DR. Detecting tumor progression in glioma: current standards and new techniques. Expert Rev Anticancer Ther. 2016 Oct 8:1-12. [Epub ahead of print] PubMed PMID: 27661768.
Eilaghi A, Yeung T, d’Esterre C, Bauman G, Yartsev S, Easaw J, Fainardi E, Lee TY, Frayne R. Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images. Biomark Cancer. 2016 Jul 3;8(Suppl 2):47-59.